Non-classical major histocompatibility complex proteins as determinants of tumour immunosurveillance.
about
Alteration of HLA-F and HLA I antigen expression in the tumor is associated with survival in patients with esophageal squamous cell carcinomaRemarkable conservation of distinct nonclassical MHC class I lineages in divergent amphibian speciesHighly active microbial phosphoantigen induces rapid yet sustained MEK/Erk- and PI-3K/Akt-mediated signal transduction in anti-tumor human gammadelta T-cells.Human leukocyte antigen-E alleles and expression in patients with serous ovarian cancerMutanome and expression of immune response genes in microsatellite stable colon cancerClinical relevance and functional implications for human leucocyte antigen-g expression in non-small-cell lung cancer.HLA-G expression in hematologic malignancies.The split nature of tumor-infiltrating leukocytes: Implications for cancer surveillance and immunotherapy.At the Bench: Preclinical rationale for exploiting NK cells and γδ T lymphocytes for the treatment of high-risk leukemias.Identification of a panel of ten cell surface protein antigens associated with immunotargeting of leukemias and lymphomas by peripheral blood gammadelta T cells.Reduced expression of the murine HLA-G homolog Qa-2 is associated with malignancy, epithelial-mesenchymal transition and stemness in breast cancer cells.Hsp72 mediates stronger antigen-dependent non-classical MHC class Ib anti-tumor responses than hsc73 in Xenopus laevisTumor cell recognition by γδ T lymphocytes: T-cell receptor vs. NK-cell receptors.Xenopus, a unique comparative model to explore the role of certain heat shock proteins and non-classical MHC class Ib gene products in immune surveillance.Human leukocyte antigen-G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma.Differential oxidative status and immune characterization of the early and advanced stages of human breast cancer.
P2860
Q28265651-82E3A41E-5E2B-42F7-B359-6A7EA3D5D0C2Q28742320-3BF14A0F-0AC9-4DED-BB79-C2D788781D53Q33455830-23C33D1F-5002-4900-9E84-29112E5925E4Q35674162-83FFBE5A-C6B1-475D-A56D-A06CB27DB65CQ37109573-03F25662-F298-4DE2-B8CC-22D30F4C7C29Q37293938-8F27637F-8AA8-4E22-A1DF-2769510763EFQ37810072-008E53F2-01D5-4B5B-A717-8ACE5F8ED1B6Q38039112-2F5FEBBD-AFC8-4C17-B928-44952382E082Q38151057-22AEE1A1-4B9B-4FD9-9290-A04B7F0D03A0Q39729244-B4AB48CC-B475-46BD-87DF-2F0C5ADFFA03Q41108937-63F911E8-EC19-49E7-A479-5369D74CC2CFQ41991170-932386B0-F116-4BDD-B087-0C20DE9CAA18Q42086300-1E2F172F-1451-499E-B7DD-17DFA241E50FQ42187088-FDB31C15-2855-4F06-B550-B5D312811CABQ45061505-2DACC52F-1FB9-44C6-8D3C-04D03C9D1F4CQ53279443-D069B958-DFD3-4B94-80C9-77FFD3237B59
P2860
Non-classical major histocompatibility complex proteins as determinants of tumour immunosurveillance.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Non-classical major histocompa ...... of tumour immunosurveillance.
@en
type
label
Non-classical major histocompa ...... of tumour immunosurveillance.
@en
prefLabel
Non-classical major histocompa ...... of tumour immunosurveillance.
@en
P2093
P2860
P50
P356
P1433
P1476
Non-classical major histocompa ...... s of tumour immunosurveillance
@en
P2093
Anita Q Gomes
Bruno Silva-Santos
Daniel V Correia
P2860
P304
P356
10.1038/SJ.EMBOR.7401090
P577
2007-11-01T00:00:00Z